BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Treatment
35 results:

  • 1. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
    Mikhael S; Kurdi A; Khoueiry-Zgheib N; Tahtouh R; Nasr R; Hilal G
    PLoS One; 2024; 19(3):e0298127. PubMed ID: 38489280
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epigallocatechin gallate inhibits ovarian cancer cell growth and induces cell apoptosis via activation of foxo3A.
    Zhang Z; Zhang Q; Yu Y; Su S
    In Vitro Cell Dev Biol Anim; 2023 Dec; 59(10):739-746. PubMed ID: 38038884
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. foxo3 and PTEN expression in the ovary of girls with extra-gonadal cancer with or without chemotherapy treatment prior to cryopreservation.
    Albamonte MI; Calabró LY; Albamonte MS; Vitullo AD
    BMC Womens Health; 2023 Sep; 23(1):509. PubMed ID: 37737182
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Butein Inhibits Cell Growth by Blocking the IL-6/IL-6Rα Interaction in Human ovarian cancer and by Regulation of the IL-6/STAT3/foxo3a Pathway.
    Park SA; Seo YJ; Kim LK; Kim HJ; Yoon KD; Heo TH
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047012
    [No Abstract]    [Full Text] [Related]  

  • 5. SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinoma.
    Lee YM; Chen YH; Ou DL; Hsu CL; Liu JH; Ko JY; Hu MC; Tan CT
    J Pathol; 2023 Apr; 259(4):428-440. PubMed ID: 36641765
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression.
    Feng J; Ma WW; Li HX; Pei XY; Deng SL; Jia H; Ma WZ
    Front Endocrinol (Lausanne); 2022; 13():895095. PubMed ID: 35992124
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. An
    Lee CM; Kang MA; Bae JS; Park K; Yang YH; Lee J; Jang KY; Park SH
    Hum Exp Toxicol; 2022; 41():9603271221089257. PubMed ID: 35417658
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. LINC00472 suppressed by ZEB1 regulates the miR-23a-3p/foxo3/BID axis to inhibit the progression of pancreatic cancer.
    Bi C; Wang G
    J Cell Mol Med; 2021 Sep; 25(17):8312-8328. PubMed ID: 34363438
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding Mesothelin to reduce DKK1 expression and activate the SGK3/foxo3 pathway.
    Huo Q; Xu C; Shao Y; Yu Q; Huang L; Liu Y; Bao H
    Int J Biol Sci; 2021; 17(2):574-588. PubMed ID: 33613114
    [No Abstract]    [Full Text] [Related]  

  • 10. Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss.
    Shai D; Aviel-Ronen S; Spector I; Raanani H; Shapira M; Gat I; Roness H; Meirow D
    Fertil Steril; 2021 May; 115(5):1239-1249. PubMed ID: 33485607
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Oral oyster polypeptides protect ovary against d-galactose-induced premature ovarian failure in C57BL/6 mice.
    Li Y; Qiu W; Zhang Z; Han X; Bu G; Meng F; Kong F; Cao X; Huang A; Feng Z; Li Y; Zeng X; Du X
    J Sci Food Agric; 2020 Jan; 100(1):92-101. PubMed ID: 31435952
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low-dose fraction radiation.
    Zhao L; Liu S; Liang D; Jiang T; Yan X; Zhao S; Liu Y; Zhao W; Yu H
    Cancer Med; 2019 May; 8(5):2442-2448. PubMed ID: 30941896
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
    Mao W; Peters HL; Sutton MN; Orozco AF; Pang L; Yang H; Lu Z; Bast RC
    Cancer; 2019 Apr; 125(8):1267-1280. PubMed ID: 30620384
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. foxo3a Reverses the Cisplatin Resistance in ovarian cancer.
    Lu M; Chen X; Xiao J; Xiang J; Yang L; Chen D
    Arch Med Res; 2018 Feb; 49(2):84-88. PubMed ID: 29716743
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. CDK6 protects epithelial ovarian cancer from platinum-induced death via foxo3 regulation.
    Dall'Acqua A; Sonego M; Pellizzari I; Pellarin I; Canzonieri V; D'Andrea S; Benevol S; Sorio R; Giorda G; Califano D; Bagnoli M; Militello L; Mezzanzanica D; Chiappetta G; Armenia J; Belletti B; Schiappacassi M; Baldassarre G
    EMBO Mol Med; 2017 Oct; 9(10):1415-1433. PubMed ID: 28778953
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Attenuation of MUC4 potentiates the anticancer activity of auranofin via regulation of the Her2/Akt/foxo3 pathway in ovarian cancer cells.
    Bae JS; Lee J; Park Y; Park K; Kim JR; Cho DH; Jang KY; Park SH
    Oncol Rep; 2017 Oct; 38(4):2417-2425. PubMed ID: 28765909
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
    Sereni MI; Baldelli E; Gambara G; Ravaggi A; Hodge KA; Alberts DS; Guillen-Rodriguez JM; Dong T; Memo M; Odicino F; Angioli R; Liotta LA; Pecorelli SL; Petricoin EF; Pierobon M
    Br J Cancer; 2017 Aug; 117(4):494-502. PubMed ID: 28664915
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Synergistic effect of melatonin and ghrelin in preventing cisplatin-induced ovarian damage via regulation of foxo3a phosphorylation and binding to the p27
    Jang H; Na Y; Hong K; Lee S; Moon S; Cho M; Park M; Lee OH; Chang EM; Lee DR; Ko JJ; Lee WS; Choi Y
    J Pineal Res; 2017 Oct; 63(3):. PubMed ID: 28658519
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Inactivation of AKT, ERK and NF-κB by genistein derivative, 7-difluoromethoxyl-5,4'-di-n-octylygenistein, reduces ovarian carcinoma oncogenicity.
    Ning Y; Xu M; Cao X; Chen X; Luo X
    Oncol Rep; 2017 Aug; 38(2):949-958. PubMed ID: 28627607
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Paclitaxel suppresses the viability of breast tumor MCF7 cells through the regulation of EF1α and foxo3a by AMPK signaling.
    Kim JH; Lee JO; Kim N; Lee HJ; Lee YW; Kim HI; Kim SJ; Park SH; Kim HS
    Int J Oncol; 2015 Nov; 47(5):1874-80. PubMed ID: 26397839
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.